370 related articles for article (PubMed ID: 37841237)
21. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
Zhang Y; Zhou J; Li H; Liu Y; Li J
BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
[TBL] [Abstract][Full Text] [Related]
22. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.
Zhou W; Zhang W
BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504
[TBL] [Abstract][Full Text] [Related]
23. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
24. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
25. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Wang W; Cui G; Zhao S
Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013
[TBL] [Abstract][Full Text] [Related]
26. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Wang W; Wang S; Chu X; Liu H; Xiang M
J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
[TBL] [Abstract][Full Text] [Related]
27. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients.
Yan D; Chen Y
Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Glycolysis-Related Genes in Lung Squamous Cell Carcinoma.
Kadasah SF
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256214
[TBL] [Abstract][Full Text] [Related]
29. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by Pseudogene OR7E47P-related Immune Genes.
Zhao YQ; Zhang HH; Wu J; Li L; Li J; Zhong H; Jin Y; Lei TY; Zhao XY; Xu B; Song QB; He J
Curr Med Sci; 2023 Dec; 43(6):1133-1150. PubMed ID: 38015361
[TBL] [Abstract][Full Text] [Related]
31. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
Zhang T; Yang H; Sun B; Yao F
Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
[TBL] [Abstract][Full Text] [Related]
32. A ferroptosis-related gene signature for overall survival prediction and immune infiltration in lung squamous cell carcinoma.
Miao TW; Yang DQ; Chen FY; Zhu Q; Chen X
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35866375
[TBL] [Abstract][Full Text] [Related]
33. A survival model for prognostic prediction based on ferroptosis-associated genes and the association with immune infiltration in lung squamous cell carcinoma.
Lu Y; Yang H; Cao Y; Wang Y; Wu M; He B; Xu J; Su Z; Luo W; Liu Y; Hu W
PLoS One; 2023; 18(3):e0282888. PubMed ID: 36928232
[TBL] [Abstract][Full Text] [Related]
34. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.
Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y
BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578
[TBL] [Abstract][Full Text] [Related]
35. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing.
Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K
J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453
[TBL] [Abstract][Full Text] [Related]
36. An investigation to identify tumor microenvironment-related genes of prognostic value in lung squamous cell carcinoma based on The Cancer Genome Atlas.
Liu H; Liu B; Zhang L; Li M; Chen C; He S; Luo T; He X; Tan L
Transl Cancer Res; 2021 Apr; 10(4):1885-1899. PubMed ID: 35116510
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
38. The Combined Detection of Immune Genes for Predicting the Prognosis of Patients With Non-Small Cell Lung Cancer.
Tian WJ; Liu SS; Li BR
Technol Cancer Res Treat; 2020; 19():1533033820977504. PubMed ID: 33256552
[TBL] [Abstract][Full Text] [Related]
39. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.
Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z
Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583
[TBL] [Abstract][Full Text] [Related]
40. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
